drugset / Trial / NCT00992225
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The primary purpose of this study is to determine the objective response rate (complete and partial response) for patients who receive LY573636-sodium for metastatic breast cancer.
Timeline
- Start
- 2009-09
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tasisulam | Small molecule | — | Intravenous |